Profil
Elisabeth Sthengel is currently working as Manager-Design, Development & Clinical at Invent Medic Sweden AB since 2017.
Prior to this, she worked as Laboratory Manager at NOLabs AB.
Aktive Positionen von Elisabeth Sthengel
Unternehmen | Position | Beginn |
---|---|---|
INVENT MEDIC SWEDEN AB | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 |
Ehemalige bekannte Positionen von Elisabeth Sthengel
Unternehmen | Position | Ende |
---|---|---|
NOLabs AB
NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INVENT MEDIC SWEDEN AB | Health Technology |
Private Unternehmen | 1 |
---|---|
NOLabs AB
NOLabs AB Medical SpecialtiesHealth Technology NOLabs AB is a holding company that explores and develops proprietary therapies for diabetic patients where current treatment options are insufficient or complicated. It is a medical device company that focuses on its core technology, as well as the development of therapeutic applications for diabetic pain relief. Its product contains NitroSense Nitric Oxide (NO) delivery system and is a multilayer patch that is designed to release NO in a controlled manner. The firm core concept of NitroSense Technology is combining a substance and a delivery system to create h products for local delivery of NO. The company was founded in 2004 and is headquartered in Helsingborg, Sweden. | Health Technology |